Navigation Links
The Foundry Announces New Partners and Completion of Series A Financing for Eleventh Company
Date:1/28/2009

Corporate Affairs and General Counsel since 2003. Prior to that, Mr. Grainger was the Founder, Chief Strategy Officer, and member of the Board of Directors of First to File, Inc., a developer of software and services for automating patent process workflow which was acquired by Mark Monitor. From 1993-2000, Mr. Grainger served as Chief Patent Counsel of Heartport, Inc., a developer of devices for minimally-invasive heart surgery which was acquired by Johnson & Johnson. From 1991-1993, Mr. Grainger was an attorney at the law firm of Townsend & Townsend & Crew. Prior to entering law school, Mr. Grainger worked as a Robotics Engineer at Boeing Electronics Company. Mr. Grainger holds a Juris Doctor degree with Honors from the University of Washington and a BS in Mechanical Engineering from Stanford University.

"We are extremely pleased to add Erik and Jeff to The Foundry team," said Mr. Gifford. "With the closing of this financing and our enhanced team, we are poised to break exciting new ground with our eleventh company." Foundry Newco XI is currently not disclosing its product or market plans. The $5 M Series A financing will provide the resources to continue inventing, developing and commercializing breakthrough solutions to major unmet medical needs. Split Rock Partners and Morgenthaler Ventures co-led the Series A financing. Allan Will, founding Managing Director of Split Rock Venture Partners, will continue as chairman of The Foundry, and Hank Plain, Partner of Morgenthaler Ventures, will continue to serve as Vice Chairman.

About The Foundry

The Foundry was co-founded in 1998 by Allan Will and Hanson Gifford, to rapidly turn the best concepts into successful new medical device companies. In addition to inventing new technologies itself, The Foundry works closely with outside clinicians and inventors with promising ideas. Over the past ten years, The Foundry h
'/>"/>

SOURCE Split Rock Partners
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Sonic Foundry to Host Wisconsin Lt. Governor Lawton in Raising Awareness for National Depression Screening Day
2. Align Technology Announces Fourth Quarter and Fiscal 2008 Results
3. Solta Medical, Inc. Announces Preliminary Financial Results for the Fourth Quarter of 2008
4. Versus Technology, Inc. Announces Expansion of Real-Time Location System to Include Anesthesia Clinic at PeaceHealth RiverBend Campus
5. Perrigo Company Announces Quarterly Dividend
6. Cardiogenesis Announces Successful Educational Symposium at Society of Thoracic Surgeons Meeting in San Francisco
7. Nuvo Research Announces Successful Completion Of All Pennsaid(R) Studies
8. BD Announces Results for First Fiscal Quarter
9. Purkinje Announces EMR Promotions in Support of National Healthcare Reform Initiatives
10. NHP Announces Fourth Quarter Earnings Release Date and Conference Call/Webcast
11. Jenny Craig Announces Nationwide Voluntary Recall of Jennys Cuisine(R) Anytime Peanut Butter Flavor Nutritional Bars Due to Possible Peanut Corporation of America (PCA) Contamination and Potential Health Risk

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., EDINA,Minn.,Nov.25/PRNewswire-USNewswire/--Whe...st.Butachiropractorcanalsogivepatientsthehelptheyn...swhereyourjaw(mandible)contacts/connectswithyoursk...ciatedwithTMJdysfunctionarepainwithchewing,clickin...fromTMJdysfunctionincluding:headaches,fatigue,slee...
(Date:11/25/2009)..., TORONTOandCALGARY,Nov.25/PRNewswire/-Sentinell...ceImaging(MRI)coilsandsoftwareandCalgaryScientific...s,haveintroducedawebversionofAegis(TM)Breast4DAdva...erfaceisthefirsttrulyzero-footprintWebclientbasedm...,sPureWeb(TM)platformallowsforzero-footprintaccess...
(Date:11/25/2009)..., SILVERSPRING,Md.,Nov.25/PRNewswire-USNewswire/...CenterforDrugEvaluationandResearch,titled"ADifficu...earsintheNov.26,2009issueofTheNewEnglandJournalofM...in/prnh/20090824/FDALOGO ) ,, Inthearticle,Wood...sstopainmedicationforthosewhoneeditandmanagingther...
(Date:11/25/2009)..., BroadPoliticalEndorsements,Business,andPressJ...ewswire-USNewswire/--Onceagain,theNationalBipolarF...ationendorsingtheir"Safe,tilStable"program,whichis...reforbipolardisorder.Today,theNationalBipolarFound...xpressPriorityMailfromtheLt.GovernorofLouisianaMit...
(Date:11/25/2009)...A fortuitous discovery that grew out of a collabor...potentially offer hope to the nearly 10 million Am...e. , Also known as hardening of the arteries... circulatory problem in which narrowed arteries re...sidered a red flag for vascular disease, heart att...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4
...issue that children,often face on a regular basis,...o communicate effectively to handle a confrontatio...ool bullies. These rivalries can be harmful,to chi...establish and maintain a home environment where,co...
...eedom to Breathe Act, MINNEAPOLIS, Sept. 10 Toda...designed to educate and excite Minnesotans about t...e law that goes into effect,on October 1. The new ...y ClearWay Minnesota(SM). The majority of,the camp...
...es know that damage to a tendon can signal an end ...f scientists, led in part by University of Souther...Songtao Shi, has identified unique cells within th...lls and regenerate tendon-like tissue in the anima...
...at the Stanford University School of Medicine have... cells within living animals. Their goal is to use...of cancer and other diseases. , The probe,s main ...ble to the naked eye but it carries a fluorescent ...
... Press,Club,s 10th Annual 5K race today, which sta...h & F in Washington, Weiner Public News was first ...reporting and op-ed writing,division of Robert Wei...ted over 500 radio and TV interviews. Weiner,webma...
...s to monitor eyesight carefully , , SATUR... to monitor themselves for eyesight problems, whic...the American Geriatrics Society (AGS). If not prop...hanges in vision will not only hinder a person,s a...
Other Medicine News:Health News:Tips for Parents: Teaching Children to Resolve Conflicts 2Health News:Fresh Air Campaign to Showcase Minnesotans' Love of Smoke-Free Air 2Health News:USC researcher identifies stem cells in tendons that regenerate tissue in animal model 2Health News:Molecular probe 'paints' cancer cells in living animals, Stanford researchers find 2Health News:Molecular probe 'paints' cancer cells in living animals, Stanford researchers find 3Health News:Weiner Public News First Media Team at National Press Club 5K 2Health News:Poor Senior Vision Often a Window on Disease 2
(Date:11/25/2009)... CHAPELHILL,N.C.,Nov.25/PRNewswire/--CempraPharmac...,presidentandchiefexecutiveofficer,willpresentatth....m.EST,December1,2009,atTheNewYorkPalaceHotelinNew...pany,stwoleadingantibioticclinicalprogramsforthetr..., AboutCempraPharmaceuticals ,, Foundedin200...
(Date:11/25/2009)... NEWYORK,Nov.25/PRNewswire/--Reportlinker.comannou...talogue: ,, IntranasalDrugDelivery-USMarketTre...4267/Intranasal-Drug-Delivery---US-Market-Trends--...rketiswitnessinganexpansionoftherapeuticapplicatio...gstothedeliveryofsystemictherapeuticdrugs.Thefutur...
(Date:11/25/2009)... FRAMINGHAM,Mass.andSYDNEY,Nov.25/PRNewswire-First...SX:HIN),aleadinginnovatorandprovideroflessinvasive...ionizingthetreatmentofadvancedheartfailure,todayan...onatthe21stAnnualPiperJaffrayHealthCareConferencea...isbeingheldattheNewYorkPalaceHotel,December1-2. ,...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5bioTheranostics Announces Commercial Agreement With Lab21 to Market THEROS CancerTYPE ID 28R 29 Molecular Cancer Classifier in United Kingdom Ireland 58927 1bioTheranostics Announces Commercial Agreement With Lab21 to Market THEROS CancerTYPE ID 28R 29 Molecular Cancer Classifier in United Kingdom Ireland 58927 2bioTheranostics Announces Commercial Agreement With Lab21 to Market THEROS CancerTYPE ID 28R 29 Molecular Cancer Classifier in United Kingdom Ireland 58927 3R Tech Ueno Starts Early Phase II Clinical Trial for RK 023 5244 1R Tech Ueno Starts Early Phase II Clinical Trial for RK 023 5244 2R Tech Ueno Starts Early Phase II Clinical Trial for RK 023 5244 3People with Disabilities Face Unique Healthcare Coverage Challenges Allsup Says 58921 1People with Disabilities Face Unique Healthcare Coverage Challenges Allsup Says 58921 2People with Disabilities Face Unique Healthcare Coverage Challenges Allsup Says 58921 3People with Disabilities Face Unique Healthcare Coverage Challenges Allsup Says 58921 4People with Disabilities Face Unique Healthcare Coverage Challenges Allsup Says 58921 5People with Disabilities Face Unique Healthcare Coverage Challenges Allsup Says 58921 6
... in Advanced Cancer Patients, ROCKVILLE, Md., Apr...nical-stage pharmaceutical company developing,ther...ory diseases, today,announced that it has commence...ith its oral cell cycle inhibitor, MKC-1, in patie...clinical trial will be conducted at the,University...
... funding CoAxia,s studies of its NeuroFlo(TM) ...Stroke, MINNEAPOLIS, April 1, 2008 CoAxia(TM), I...g of an additional $11.5M financing,from current i...ngoing,clinical trials. The investment is an exten...allow CoAxia to continue its SENTIS pivotal FDA tr...
Other Medicine Technology:EntreMed Commences Continuous Dosing Clinical Trial For MKC-1 2EntreMed Commences Continuous Dosing Clinical Trial For MKC-1 3EntreMed Commences Continuous Dosing Clinical Trial For MKC-1 4CoAxia(TM) Announces $11.5M Equity Financing From Existing Investors 2
...tretch Vascular Grafts have met the challenges of ... for exceptional performance and quality, they hav...dwide. These grafts require no preclotting, resist...e utmost thrombectomy safety. The GORE-TEX Stretch...
...olving techniques for vascular surgery, and the ac...that new, specialized types of graft be developed....atible, but also available in varying sizes and co...X Vascular Graft has long been the prosthetic of c...
...ascular Grafts have met the challenges of the most...Recognized for exceptional performance and quality...geons worldwide. These grafts require no preclotti... and assure utmost thrombectomy safety. The Gore v...
...eg; Vascular Grafts have met the challenges of the...ars. Recognized for exceptional performance and qu...d surgeons worldwide. These grafts require no prec...tion, and assure utmost thrombectomy safety. Gore ...
Medicine Products: